GE Aerospace vs Herbalife Nutrition Ltd — how do they compare? GE Aerospace trades at $308.2 (market cap $317.10B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: GE Aerospace is far larger — about 236.6× Herbalife Nutrition Ltd's market cap, and GE Aerospace pays a 0.62% dividend while Herbalife Nutrition Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold GE Aerospace for 111 Days and Herbalife Nutrition Ltd for 43 Days on average.
| GE | HLF | |
|---|---|---|
Market Cap | $317.10B | $1.34B |
Volume | 6,320,106 | 1,589,457 |
Sector | Industrials | Consumer Staples |
52-Week High | $381.22 | $19.96 |
52-Week Low | $273.25 | $7.75 |
Typical Hold Time | 111 Days | 43 Days |
Enterprise Value | $326.91B | $3.18B |
Dividend Yield | 0.62% | — |
Signals from Pluang's Aura AI — not financial advice
GE Aerospace (GE) trades at $305.62, up 0.66% on the day, but faces a near-term bearish technical signal despite strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $2.02 exceeding the $1.86 estimate. Revenue growth is accelerating, reaching $45.86 billion in 2025, while net income margins improved to 17.72%. However, the stock's high valuation multiples, including a P/E of 36.04, and a significant $12 billion acquisition of Consolidated Precision Products, present both opportunity and scrutiny.
The outlook remains positive driven by strong defense demand and shareholder returns, including a $20 billion buyback and raised dividend. Analyst consensus is strongly bullish with a $409.60 price target, though risks include integration challenges from the CPP deal, cost pressures, and high debt levels. The stock's current price is approximately 25% below the consensus target, suggesting potential upside if execution risks are managed.
HLF trades at $12.82, up 1.34% today, with a bullish technical signal from moving averages and oscillators. The company reported mixed quarterly earnings, beating in Q1 2026 but missing in Q4 2025 and Q2 2026. Revenue has been stable around $5.0B annually, with a net income margin of 4.53% in 2025. Recent news includes a $250 million share repurchase program and a planned CEO transition effective October 31, 2026.
The stock appears undervalued with a P/E of 8.22 and P/S of 0.26, supported by a 53.84% analyst buy rating and a $19.00 consensus price target. Key risks include high debt levels, with total liabilities at $3.53B, and inconsistent earnings performance. Positive cash flow trends in 2026 projections and margin expansion plans offer potential upside, but investor caution is warranted due to ongoing leadership changes and competitive pressures.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
General Electric Company is a globally diversified technology and financial services company. The Company's products and services include aircraft engines, power generation, water processing, and household appliances to medical imaging, business and consumer financing, and industrial products.
Read more on GE →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →